Skip to main content

Table 3 Comparison of patients group with para-aortic lymph node surgery

From: Role of pelvic and para-aortic lymphadenectomy in abandoned radical hysterectomy in cervical cancer

  Tumor removal and/or para-aortic biopsy
N = 14 (70.0%)
Para-aortic lymphadenectomy
N = 6 (30.0%)
p
Countrya
 Mexico (INCan) 5 (35.7) 2 (33.3) 0.26
 Colombia (ICLA) 9 (64.3) 4 (66.7)
Age (years)b 45 (40–45) 44.5 (42–50) 0.90
BMIb 26.55 (23.7–28.3) 23.9 (22.5–32.7) 0.60
Histologya
 Squamous 6 (42.9) 3 (50) 0.02
 Adenocarcinoma 5 (35.7) 3 (50)
 Adenosquamous 1 (7.1) 0
 Others 2 (14.3) 0
Initial clinical stagea
 IB1 12 (85.7) 6 (100) <0.001
 IB2 2 (14.3) 0
Tumor size (cm)b 3.5 (2–4) 3.15 (2.9–4)  
Tumor gradea
 Well-differentiated 4 (28.6) 3 (50) 0.95
 Moderately differentiated 3 (21.4) 3 (50)
 Poorly differentiated 7 (0.5) 0
LVSIa 3 (21.4) 0 0.09
PR positive 6 (42.9) 1 (16.7) 0.354
Surgical time (min)b 172.5 (90–195) 120 (100–195) 0.78
Blood loss (mm)b 100 (70–300) 140 (100–250) 0.72
Blood transfusiona 0 0 NS
Others complicationsa 0 1 (16.7) <0.001
Hospital stay (days)b 2 (2–2) 2 (2–3) 0.44
Neoadjuvant treatment term (weeks)b 10.5 (8.2–14.2) 10.5 (8–15.4) 0.66
Recurrencea
 Local 0 1 (16.7) <0.001
 Regional 3 (21.4) 0
 Distance 3 (21.4) 0
  1. Confidence interval 95%
  2. BMI body mass index, Mod moderate, LVSI lymphovascular space involvement, PR pathology report
  3. a N (relative frequency)
  4. bMedian (interquartile range)